Tech Company Financing Transactions
Adcentrx Therapeutics Funding Round
Adcentrx Therapeutics, operating out of San Diego, secured $13 million in investment from Partners Investment and Quan Capital.
Transaction Overview
Company Name
Announced On
12/6/2023
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to continue advancing its propriety ADC therapeutic pipeline in the clinic.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5580 Morehouse Dr, 210
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
At Adcentrx, we are driven to create the best therapies to treat serious and life-threatening diseases. By leveraging a deep understanding of chemistry and biology, our goal is to purposefully solve the issues faced by ADCs in the past and develop improved protein conjugate therapies for patients with the highest unmet needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hui Li
Chief Scientific Officer
Pia Challita-Eid
Vice President
Alex Chu-Kung
Browse more venture capital transactions:
Prev: 12/5/2023: Rightbot venture capital transaction
Next: 12/6/2023: VAST Data venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs